Timing matters: Real-world effectiveness of early combination of biologic and conventional synthetic disease-modifying antirheumatic drugs for treating newly diagnosed polyarticular course juvenile idiopathic arthritis.
Huang, B; Qiu, T; Chen, C; Zhang, Y; Seid, M; Lovell, D; Brunner, HI; Morgan, EM; PCATS, .
RMD Open.
2020;
6:e001091-e001091.
Immunome perturbation is present in patients with juvenile idiopathic arthritis who are in remission and will relapse upon anti-TNFα withdrawal.
Leong, JY; Chen, P; Yeo, JG; Ally, F; Chua, C; Hazirah, SN; Poh, SL; Pan, L; Lai, L; Lee, ES C; et al.
Annals of the Rheumatic Diseases.
2019;
78:1712-1721.
Effectiveness of long-term infliximab use and impact of treatment adherence on disease control in refractory, non-infectious pediatric uveitis.
Utz, VM; Bulas, S; Lopper, S; Fenchel, M; Sa, T; Mehta, M; Ash, D; Lovell, DJ; Kaufman, AH.
Pediatric Rheumatology Online Journal.
2019;
17.
Severe autoinflammation in 4 patients with C-terminal variants in cell division control protein 42 homolog (CDC42) successfully treated with IL-1β inhibition.
Gernez, Y; de Jesus, AA; Alsaleem, H; Macaubas, C; Roy, A; Lovell, D; Jagadeesh, KA; Alehashemi, S; Erdman, L; Grimley, M; et al.
Journal of Allergy and Clinical Immunology.
2019;
144:1122-1125.e6.
Establishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA Workshop.
Morgan, EM; Munro, JE; Horonjeff, J; Horgan, B; Shea, B; Feldman, BM; Clairman, H; III, BC O; Thornhill, S; Strand, V; et al.
The Journal of rheumatology.
2019;
46:1006-1013.
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.
Angeles-Han, ST; Ringold, S; Beukelman, T; Lovell, D; Cuello, CA; Becker, ML; Colbert, RA; Feldman, BM; Holland, GN; Ferguson, PJ; et al.
Arthritis and Rheumatology.
2019;
71:864-877.
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.
Angeles-Han, ST; Ringold, S; Beukelman, T; Lovell, D; Cuello, CA; Becker, ML; Colbert, RA; Feldman, BM; Holland, GN; Ferguson, PJ; et al.
Arthritis Care and Research.
2019;
71:703-716.
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis.
Ringold, S; Angeles-Han, ST; Beukelman, T; Lovell, D; Cuello, CA; Becker, ML; Colbert, RA; Feldman, BM; Ferguson, PJ; Gewanter, H; et al.
Arthritis Care and Research.
2019;
71:717-734.
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis.
Ringold, S; Angeles-Han, ST; Beukelman, T; Lovell, D; Cuello, CA; Becker, ML; Colbert, RA; Feldman, BM; Ferguson, PJ; Gewanter, H; et al.
Arthritis and Rheumatology.
2019;
71:846-863.
American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus.
Brunner, HI; Holland, MJ; Beresford, MW; Ardoin, SP; Appenzeller, S; Silva, CA; Flores, F; Aydin, PO A; Wenderfer, SE; Levy, DM; et al.
Arthritis Care and Research.
2019;
71:579-590.